ライフサイエンスコーパス: Salmonella typhi

1 s tissue polymerase chain reaction [PCR] for Salmonella Typhi).

2 ococcus and the other by the PocR protein of Salmonella typhi.

3 murium and closely related organisms such as Salmonella typhi.

4 a typhimurium and between S. typhimurium and Salmonella typhi.

5 treptococcus pneumoniae, and, more recently, Salmonella typhi.

6 yphoidal Salmonella (NTS) serotypes, and 126 Salmonella Typhi.

7 reliably detect 1 colony-forming unit/mL of Salmonella Typhi.

8 otection against the intracellular bacterium Salmonella Typhi.

9 ciency virus type 1, Epstein Barr virus, and Salmonella typhi.

10 tal absence of bactericidal activity against Salmonella typhi 0 901 and Hemophilus influenzae, type b

11 these, 304 (5.3%) were culture positive for Salmonella Typhi (249 [81.9%]) or Paratyphi A (55 [18.1%

12 ctor of the human-adapted bacterial pathogen Salmonella Typhi (6,7) , the cause of typhoid fever in h

13 Of 129 Salmonella Typhi, 89 (89.9%) were resistant to amoxicill

14 The Vi capsular polysaccharide of Salmonella typhi, a licensed vaccine for typhoid fever i

15 in children and adults, respectively, while Salmonella Typhi accounted for 0.5% and 2.1%, respective

16 Salmonella Typhi activates the host DNA damage response

17 To survive in human macrophages, Salmonella Typhi actively counteracts the Rab32/BLOC-3 p

18 ts was 13.1 (6.3-28.0) months for those with Salmonella Typhi and 11.5 (8.5-23.4) months for NTS.

19 Of these, 7,591 (87%) were Salmonella Typhi and 1114 (13%) were S. Paratyphi.

20 drug resistance was present in 68 (81.0%) of Salmonella Typhi and 12 (41.4%) of NTS.

21 single dose of Vi polysaccharide vaccine for Salmonella typhi and 2 doses of rabies vaccine were give

22 94% (2093/2230) of isolates were Salmonella Typhi and 6% (137/2230) were S. Paratyphi.

23 %) isolates were available for analysis (164 Salmonella Typhi and 784 iNTS).

24 period at YGH, we identified 33 (4.9%) with Salmonella Typhi and 9 (1.3%) with Salmonella Paratyphi

25 ide antigen Vi (anti-Vi) IgG and IgA against Salmonella Typhi and anti-lipopolysaccharide (LPS) IgG a

26 are a significant transmission mechanism for Salmonella typhi and dysentery-causing pathogens in this

27 Salmonella Typhi and iNTS were cultured from 194 (1.4%)

28 udy reports the microbiological landscape of Salmonella Typhi and invasive nontyphoidal Salmonella (i

29 The epidemiology of Salmonella Typhi and invasive nontyphoidal Salmonella (N

30 Salmonella enterica including Salmonella Typhi and nontyphoidal Salmonella (NTS) are t

31 Salmonella Typhi and NTS are major causes of BSI in DRC;

32 A panel of 17 Salmonella Typhi and Paratyphi A antigens was purified a

33 en applied to hospital-based surveillance of Salmonella Typhi and Paratyphi A bloodstream infections

34 ated antimicrobial susceptibility results of Salmonella Typhi and Paratyphi A isolates sent for testi

35 4 and 57 centisomes on the physical maps of Salmonella typhi and S. typhimurium, respectively.

36 ound to be effective for multidrug-resistant Salmonella typhi and safe in the pediatric population.

37 The host-pathogen interactions induced by Salmonella Typhi and Salmonella Paratyphi A during enter

38 erase chain reaction (qPCR) method to detect Salmonella Typhi and Salmonella Paratyphi A simultaneous

39 The probe set was able to detect clinical Salmonella Typhi and Salmonella Paratyphi A strains and

40 Enteric fever, caused by Salmonella Typhi and Salmonella Paratyphi A, is the lead

41 agriculture are key transmission routes for Salmonella Typhi and Salmonella Paratyphi A.

42 yphoidal salmonellosis (infections caused by Salmonella Typhi and Salmonella Paratyphi), this disorde

43 s an enteric disease caused by the pathogens Salmonella Typhi and Salmonella Paratyphi.

44 Salmonella Typhi and Typhimurium diverged only approxima

45 almonella enterica of which 129 (75.4%) were Salmonella Typhi, and 42 (24.6%) were NTS.

46 acute phase of human typhoid fever caused by Salmonella typhi, and experimental murine salmonellosis

47 various pathogens (Streptococcus pneumoniae, Salmonella typhi, and Mycobacterium tuberculosis), we de

48 previously identified several immunoreactive Salmonella Typhi antigens that seem promising for possib

49 Salmonella Typhi assembles and secretes two forms of typ

50 ccines and were subsequently challenged with Salmonella Typhi bacteria.

51 ew of a decade (2007-2017) of hospital-based Salmonella Typhi bloodstream infection (BSI) surveillanc

52 Children <5 years accounted for 20.3% of Salmonella Typhi BSI episodes.

53 to restrict the intracellular human pathogen Salmonella Typhi, but its potential broader role in anti

54 have been implicated in the transmission of Salmonella Typhi, but the dominant transmission pathways

55 purified capsular polysaccharide Vi Ag from Salmonella typhi can protect against typhoid fever, alth

56 ronic infection with other bacteria, notably Salmonella typhi, can also facilitate tumour development

57 Typhoid fever, primarily caused by Salmonella Typhi, can result in severe life-threatening

58 the relative virulence of newly constructed Salmonella typhi carrier strains.

59 m Vi antibody measurements to detect chronic Salmonella Typhi carriers.

60 Shigella sonnei and Salmonella Typhi cause significant morbidity and mortali

61 Salmonella enterica serovar Typhi (Salmonella Typhi) causes an estimated 22 million typhoid

62 as Pseudomonas aeruginosa dTDP-Glc PPase and Salmonella typhi CDP-Glc PPase.

63 1.35 A of the crystal structure of DHQ1 from Salmonella typhi chemically modified by this ammonium de

64 gene and did not belong to the dominant H58 Salmonella Typhi clade.

65 es, in this work we evolved Cytolysin A from Salmonella typhi (ClyA) to a high level of soluble expre

66 ographic analysis of tyvelose epimerase from Salmonella typhi complexed with CDP.

67 ers requires the specific environment of the Salmonella Typhi-containing vacuole, which is determined

68 Salmonella typhi continues to cause severe disease in ma

69 Salmonella Typhi contributed most to the enteric fever h

70 y a thorough analysis on the well-understood Salmonella typhi CT18 genome.

71 agments thereof were expressed in attenuated Salmonella typhi CVD 908-htrA, and the constructs were t

72 In Salmonella Typhi, efficient export and cell-surface rete

73 The disease is initiated when Salmonella typhi enters gastrointestinal epithelial cell

74 ic investigations have demonstrated that the Salmonella typhi enzyme complexed with the product CDP-g

75 , the intracellular bacterial human pathogen Salmonella Typhi exhibits strict host specificity.

76 gens, including the human exclusive pathogen Salmonella Typhi, express capsular polysaccharides as a

77 Recently, we have demonstrated that Salmonella typhi flagella (STF) markedly decrease CD14 e

78 lood mononuclear cells (PBMC) in response to Salmonella typhi flagella (STF) were examined in culture

79 presentation 2; lymphocyte proliferation to Salmonella Typhi flagellin occurred in 63% and 67% of su

80 ly bind to the hemolysin E (HlyE) antigen of Salmonella Typhi for future development of typhoid diagn

81 TF); a confirmed case required isolation of Salmonella Typhi from blood or stool.

82 ization of mice with live typhoidal serovar, Salmonella Typhi, generates cross-reactive immune respon

83 mviA+ with that of the Escherichia coli and Salmonella typhi genes revealed a high degree of conserv

84 ophage elements present in the two published Salmonella typhi genomes, and in the database sequences

85 idence of the transcontinental spread of the Salmonella Typhi H58 haplotype, improved estimates of th

86 a composite antibiotic resistance island in Salmonella Typhi Haplotype 58.

87 immunized by the i.p. route with attenuated Salmonella typhi harboring the same DNA vaccine plasmid,

88 Vi antigen, the virulence factor of Salmonella typhi, has been used clinically as a molecula

89 The DNA aptamers against Salmonella Typhi HlyE were isolated using systematic evo

90 rces, patterns, and modes of transmission of Salmonella Typhi in diverse settings.

91 ntified an outbreak of ceftriaxone-resistant Salmonella Typhi in Hyderabad, Pakistan, through antimic

92 of third-generation cephalosporin resistant Salmonella Typhi in Mumbai, linked to the acquisition an

93 tify genes required for early replication of Salmonella Typhi in vivo.

94 ctious bacteria Salmonella enterica serovar (Salmonella typhi) in 10 muL of sample volume.

95 Invasive S. typhimurium and Salmonella typhi, independent of their ability to replic

96 ct association and causal mechanisms between Salmonella Typhi infection and GBC have not been establi

97 ntrol study of 45 patients and 123 controls, Salmonella Typhi infection was associated with drinking

98 epidemiological association between GBC and Salmonella Typhi infection, we show that Salmonella ente

99 of a suitable animal model in which to study Salmonella Typhi infection.

100 a more host-restricted lifestyle typical of Salmonella Typhi infections.

101 Furthermore, whereas control Salmonella typhi invaded all monolayer cells within 1 h,

102 Kinetic studies of Salmonella typhi invasion of INT407 cells at different m

103 In addition to Salmonella Typhi, invasive nontyphoidal Salmonella are i

104 Salmonella Typhi is a human host-restricted pathogen tha

105 Salmonella Typhi is a human-restricted pathogen that is

106 Salmonella Typhi is a major cause of fever in children i

107 Typhoid fever caused by Salmonella Typhi is a major public health concern in low

108 Salmonella Typhi is an exclusive human pathogen that cau

109 hoid fever caused by multidrug-resistant H58 Salmonella Typhi is an increasing public health threat i

110 Salmonella Typhi is the cause of typhoid fever, a diseas

111 Salmonella typhi is the etiologic agent of human typhoid

112 Salmonella Typhi is the leading cause of childhood bacte

113 enterica subspecies enterica serovar Typhi (Salmonella Typhi) is the cause of typhoid fever and a hu

114 Seventy-four Salmonella Typhi isolates (25%) were resistant to 1 or m

115 Two MDR Salmonella Typhi isolates from India were found by whole

116 84/351) of NTS isolates and 46.2% (12/26) of Salmonella Typhi isolates.

117 gel electrophoresis (PFGE) were performed on Salmonella Typhi isolates.

118 enomic profiles of Salmonella serovar Typhi (Salmonella Typhi) isolates from the 15 confirmed case su

119 Immunogenicity data included Salmonella Typhi lipopolysaccharide (LPS)-specific immun

120 sion plasmids encoding foreign antigens in a Salmonella typhi live-vector vaccine strain such as CVD

121 [ELISPOT] assay), IgG serologic responses to Salmonella Typhi LPS, lymphocyte proliferation, and inte

122 hoprim-sulfamethoxazole (multidrug-resistant Salmonella Typhi [MDRST]).

123 e 392 cases of NTS meningitis and 9 cases of Salmonella Typhi meningitis.

124 an unusual biology in that it is produced by Salmonella Typhi only when located within host cells.

125 ucture potential was conserved in homologous Salmonella typhi operons.

126 Six Salmonella Typhi or Paratyphi human challenge studies we

127 Shedding of Salmonella Typhi or Paratyphi in the stool or urine lead

128 ard for diagnosis of enteric fever caused by Salmonella Typhi or Salmonella Paratyphi A or B is bone

129 Attenuated Salmonella typhi organisms which express genes encoding

130 mants containing pACTIItraQ plasmids and the Salmonella typhi pED208 traA gene cloned in pAS1CYH2.

131 is, Pseudomonas aeruginosa, Vibrio cholerae, Salmonella typhi, Porphyromonas gingivalis, and the mala

132 Environmental surveillance (ES) for Salmonella Typhi potentially offers a low-cost tool to i

133 Salmonella Typhi ranked first among the BSI pathogens in

134 d specificity of nine commercially available Salmonella Typhi rapid diagnostic tests (RDTs) using blo

135 Among Salmonella Typhi, rates of multidrug resistance and decr

136 All commercially available Salmonella Typhi RDTs evaluated in the study had sensiti

137 Enteric fever caused by Salmonella Typhi remains a major public health problem i

138 Reports from Asia of decreased Salmonella typhi resistance to chloramphenicol, attribut

139 , the gene encoding CDP-paratose synthase in Salmonella typhi, rfbS, has been identified and sequence

140 les was developed for the rapid detection of Salmonella typhi (S. typhi) in human serum.

141 going outbreak of extensively drug-resistant Salmonella Typhi (S. Typhi) in Pakistan has left azithro

142 Salmonella Typhi (S. Typhi) is normally not capable of p

143 ausing extremely lethal water borne pathogen Salmonella typhi (S. typhi) on modified isopore polycarb

144 tudied and inhibition zones of Gram negative Salmonella typhi (S. typhi), Klebsiella spp., Escherichi

145 Salmonella Typhi (S. Typhi), the causative agent of typh

146 etection of flagellin specific antibodies of Salmonella typhi (S. typhi).

147 provide insight into the molecular bases for Salmonella Typhi's host specificity and may help the dev

148 inhibiting effect against Escherichia coli, Salmonella typhi, Shigella dysenteriae, Streptococcus pn

149 ntibodies, which may provide immunity toward Salmonella typhi, Shigella, and Escherichia coli.

150 We engineered an attenuated Salmonella Typhi strain to express and export the F1 Ag

151 Oral vaccination with live-attenuated Salmonella Typhi strain Ty21a is modestly efficacious, b

152 The lack of antibiotic resistance among the Salmonella typhi strains isolated during this period, th

153 Salmonella typhimurium and Salmonella typhi strains were examined to better define

154 monitoring of antimicrobial resistance among Salmonella Typhi strains will help determine vaccination

155 y have a fitness advantage relative to other Salmonella Typhi strains.

156 saccharide capsules (K1 in E. coli and Vi in Salmonella typhi) swam toward the anode.

157 Other major causes of FBD deaths were Salmonella Typhi, Taenia solium and hepatitis A virus.

158 Here, high-resolution crystal structures of Salmonella typhi TAG in the unliganded form and in a ter

159 ght the clear need for new and more-accurate Salmonella Typhi tests.

160 s and increasing antimicrobial resistance in Salmonella Typhi that have served to increase interest i

161 Typhoid toxin, a unique virulence factor of Salmonella Typhi (the cause of typhoid fever), recapitul

162 disease-causing bacteria, but experiments on Salmonella Typhi, the bacteria that causes Typhoid fever

163 Salmonella Typhi, the causative agent of typhoid fever,

164 d toxin is an essential virulence factor for Salmonella Typhi, the cause of typhoid fever in humans.

165 Salmonella Typhi, the cause of typhoid fever, is a bacte

166 Salmonella Typhi, the cause of typhoid fever, produces a

167 id toxin is an essential virulence factor of Salmonella Typhi, the cause of typhoid fever.

168 Salmonella typhi, the etiologic agent of typhoid fever,

169 We isolated 16 Salmonella typhi TnphoA mutants that were defective for

170 the capacity of the gram-negative bacterium Salmonella typhi to induce IL-6 in the small intestine e

171 om broad-host Salmonella Typhimurium allowed Salmonella Typhi to survive and replicate within macroph

172 B. subtilis, Enterococcus, P. aeruginosa and Salmonella typhi) to antibiotics such as ampicillin and

173 were sequenced from a shotgun library of the Salmonella typhi Ty2 genome.

174 The phoP/phoQ virulence regulatory genes of Salmonella typhi Ty2 were deleted, and the resultant str

175 to reveal metabolic changes of the typhoidal Salmonella Typhi Ty2, the nontyphoidal Salmonella Typhim

176 iella pneumoniae were compared with those of Salmonella typhi Ty2.

177 11 volunteers after rectal immunization with Salmonella typhi Ty21a.

178 ponse was generated in healthy volunteers by Salmonella typhi vaccination.

179 althy individuals were randomized to receive Salmonella typhi vaccine (a model of acute inflammation)

180 al immunization of US adults with attenuated Salmonella Typhi vaccine CVD 908-htrA.

181 Salmonella typhi vaccine strain CVD 908 can deliver hete

182 A single-dose, oral Salmonella typhi vaccine strain has been sought as a car

183 Salmonella typhi vaccine was used to generate a systemic

184 e administered a mild inflammatory stimulus, Salmonella typhi vaccine, or saline placebo to eight hea

185 conjugate of the capsular polysaccharide of Salmonella typhi, Vi, bound to nontoxic recombinant Pseu

186 In Salmonella Typhi, Vi-antigen capsule protects the bacter

187 Salmonella Typhi was a frequent cause of BSI in adults a

188 Salmonella Typhi was isolated from 11 (0.3%) children at

189 , and 47 deaths from typhoid fever occurred; Salmonella Typhi was isolated from 27 (33%) of 81 patien

190 Salmonella Typhi was isolated in 1.4% (531/37 388) and 1

191 diatric medical patients presenting to QECH; Salmonella Typhi was isolated on 2054 occasions (1.2%) a

192 eavily contaminated with fecal coliforms; no Salmonella Typhi was isolated.

193 Salmonella Typhi was the leading cause of bloodstream in

194 ion was intense, invasive NTS was common and Salmonella Typhi was uncommon, whereas the inverse was o

195 ampylobacter spp, Neisseria gonorrhoeae, and Salmonella typhi were included in the high-priority tier

196 entify genes belonging to the Fur regulon of Salmonella typhi which are absent from Escherichia coli

197 nity against pathogenic Salmonella including Salmonella Typhi which causes systemic infection, typhoi

198 almonella Typhimurium from 2002 to 2008, and Salmonella Typhi, which began in 2011 and was ongoing in

199 lucose-1-phosphate cytidylyltransferase from Salmonella typhi, which catalyzes the first step in the

200 virulence factor for the bacterial pathogen Salmonella Typhi, which causes typhoid fever in humans.